{"id":29232,"date":"2017-10-18T15:29:12","date_gmt":"2017-10-18T13:29:12","guid":{"rendered":"http:\/\/cms.munich-startup.net\/?p=29232"},"modified":"2017-10-18T13:52:31","modified_gmt":"2017-10-18T11:52:31","slug":"biotech-press-lounge-startups-izb-medical-progress","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/29232\/biotech-press-lounge-startups-izb-medical-progress\/","title":{"rendered":"Biotech Press Lounge: IZB startups working on medical progress"},"content":{"rendered":"<div class=\"entry-content\"><p><strong>On 12 October 2017, the<a href=\"\/en\/19098\/asked-at-the-izb\/\" target=\"_blank\" rel=\"noopener\"> Innovation and Start-up Center for Biotechnology (IZB)<\/a> the sixth Biotech Press Lounge in the Faculty Club G2B (Gateway to Biotech). Dr. Peter Hanns Zobel, Managing Director of the Innovation and Start-up Center for Biotechnology (IZB), emphasized in his opening speech how important it is to bring together the players of the pharmaceutical, biotech, and venture capital scene in a relaxed atmosphere and expressed his delight at the financing that was realized at the IZB in 2017. With the <a href=\"\/en\/23893\/pieris-pharmaceuticals-lands-billion-dollar-deal\/\" target=\"_blank\" rel=\"noopener\">Pieris AG<\/a>, the <a href=\"\/en\/27744\/immunic-completes-financing-round\/\" target=\"_blank\" rel=\"noopener\">Immunic AG<\/a> and the <a href=\"\/en\/28249\/pharma-exit-msd-buys-rigontec\/\" target=\"_blank\" rel=\"noopener\">Rigontec GmbH<\/a> Deals worth up to 2 billion euros were secured.<\/strong><\/p>\n<h3>\u201cReal medical progress\u201d is important<\/h3>\n<p>Current research was presented in keynote speeches. Speakers at the Biotech Press Lounge this year were Dr. Markus Dangl (Senior Vice President Research and Pre-Clinical Development at Medigene AG), Paola Casarosa (Corporate Vice President Therapeutics at B\u00f6hringer Ingelheim), and Dr. Jens Altrichter (COO of Leukocare AG). Evelyn Warner, editor-in-chief of the Labiotech.eu portal, moderated the event.<\/p>\n<blockquote><p>\u201cWe are not only pleased that our startups are closing such successful deals, but also that this research is bringing real medical progress,\u201d<\/p><\/blockquote>\n<p>so <strong>Dr. Peter Hanns<\/strong> <strong>sable<\/strong> in his opening speech. In May 2017, Pieris announced the $2.1 billion deal with AstraZeneca. The deal involves new therapies for respiratory diseases. On September 5, 2017, Immunic AG increased its Series A financing by \u20ac10 million, bringing the total raised to \u20ac31.7 million. Immunic&#039;s goal is to develop new treatments for autoimmune diseases. One day later, Rigontec GmbH was sold to Merck MSD Research Laboratories for an expected total of \u20ac349 million. This will pave the way for a new approach in immuno-oncology.<\/p>\n<blockquote><p>\u201cTo realize such visions, the IZB was built 22 years ago on the Martinsried campus,\u201d<\/p><\/blockquote>\n<p>emphasized Zobel.<\/p>\n<h3>Partnerships create significant added value<\/h3>\n<p>This was followed by presentations from Medigene, B\u00f6hringer Ingelheim, and Leukocare. Markus Dangl, Senior Vice President Research and Pre-Clinical Development at Medigene AG, explained why neoantigens are a particularly exciting topic in the field of tumor immunotherapy and how Medigene&#039;s technologies and expertise can be used to successfully treat patients with highly effective, personalized cell therapies in the future.<\/p>\n<blockquote><p>\u201cPartnerships play a strategic role in our research and development activities,\u201d<\/p><\/blockquote>\n<p>so <strong>PhD. Paola Casarosa<\/strong>, Corporate Vice President Therapeutics at B\u00f6hringer Ingelheim in your presentation.<\/p>\n<blockquote><p>&quot;This is reflected in the fact that 50 percent of our pipeline is based on external collaborations. We seek partnership opportunities across the spectrum, from universities to biotech companies, to achieve added value for patients,&quot;<\/p><\/blockquote>\n<p>explained Casarosa.<\/p>\n<p><strong>Dr. Jens Altrichte<\/strong>r, COO of Leukocare AG, explained the increasing importance of advanced formulations in biopharmaceutical product development.<\/p>\n<blockquote><p>\u201cBy considering formulation-relevant aspects at an early stage of the development process and leveraging Leukocare\u2019s expertise and technology platform, our customers can realize significant competitive advantages and successfully exploit the maximum product and market potential in the future,\u201d<\/p><\/blockquote>\n<p>Altrichter explains the company strategy.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>On October 12, 2017, the Innovation and Start-up Center for Biotechnology (IZB) hosted the sixth Biotech Press Lounge at the Faculty Club G2B (Gateway to Biotech). In his opening speech, Dr. Peter Hanns Zobel, Managing Director of the Innovation and Start-up Center for Biotechnology (IZB), emphasized the importance of bringing together players in the pharmaceutical, biotech, and venture capital industries.<\/p>","protected":false},"author":3,"featured_media":29234,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[8,1,5635],"tags":[1846,1499],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Biotech Presselounge: IZB-Startups arbeiten am medizinischen Fortschritt - Munich Startup<\/title>\n<meta name=\"description\" content=\"Am 12. Oktober 2017 veranstaltete das Innovations- und Gr\u00fcnderzentrum f\u00fcr Biotechnologie (IZB) die sechste Biotech Presse-Lounge im Faculty Club G2B.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/29232\/biotech-press-lounge-startups-izb-medical-progress\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biotech Presselounge: IZB-Startups arbeiten am medizinischen Fortschritt - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Am 12. Oktober 2017 veranstaltete das Innovations- und Gr\u00fcnderzentrum f\u00fcr Biotechnologie (IZB) die sechste Biotech Presse-Lounge im Faculty Club G2B.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/29232\/biotech-press-lounge-startups-izb-medical-progress\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:author\" content=\"https:\/\/www.facebook.com\/profile.php?id=100009572160192\" \/>\n<meta property=\"article:published_time\" content=\"2017-10-18T13:29:12+00:00\" \/>\n<meta name=\"author\" content=\"Florian Deglmann\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@FlorianDeglmann\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Florian Deglmann\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/29232\/biotech-presselounge-startups-izb-medizinischer-fortschritt\/\",\"url\":\"https:\/\/cms.munich-startup.net\/29232\/biotech-presselounge-startups-izb-medizinischer-fortschritt\/\",\"name\":\"Biotech Presselounge: IZB-Startups arbeiten am medizinischen Fortschritt - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/29232\/biotech-presselounge-startups-izb-medizinischer-fortschritt\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/29232\/biotech-presselounge-startups-izb-medizinischer-fortschritt\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2017\/10\/Biotech-Presse-Lounge-Oktober-2017-002.jpg\",\"datePublished\":\"2017-10-18T13:29:12+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/2371b77bb47cd783e9e1f88e88d9f251\"},\"description\":\"Am 12. Oktober 2017 veranstaltete das Innovations- und Gr\u00fcnderzentrum f\u00fcr Biotechnologie (IZB) die sechste Biotech Presse-Lounge im Faculty Club G2B.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/29232\/biotech-presselounge-startups-izb-medizinischer-fortschritt\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/29232\/biotech-presselounge-startups-izb-medizinischer-fortschritt\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/29232\/biotech-presselounge-startups-izb-medizinischer-fortschritt\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2017\/10\/Biotech-Presse-Lounge-Oktober-2017-002.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2017\/10\/Biotech-Presse-Lounge-Oktober-2017-002.jpg\",\"width\":1200,\"height\":800,\"caption\":\"Redner der Biotech Presselounge am 12. Oktober 2017 im IZB (v.l.n.r.): Dr. Markus Dangl, Senior Vice President Research and Pre-Clinical Development, Medigene AG Evelyn Warner, Chefredakteurin, Labiotech.eu Dr. Jens Altrichter, COO Leukocare AG Dr. Peter Hanns Zobel, Gesch\u00e4ftsf\u00fchrer IZB PhD. Paola Casarosa, Corporate Vice President Therapeutics, B\u00f6hringer Ingelheim\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/29232\/biotech-presselounge-startups-izb-medizinischer-fortschritt\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biotech Presselounge: IZB-Startups arbeiten am medizinischen Fortschritt\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/2371b77bb47cd783e9e1f88e88d9f251\",\"name\":\"Florian Deglmann\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1e3087740aeaedbec23f0c7300f1beeb?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1e3087740aeaedbec23f0c7300f1beeb?s=96&d=blank&r=g\",\"caption\":\"Florian Deglmann\"},\"description\":\"Der Exil-N\u00fcrnberger erforschte bis April 2019 als Redakteur die M\u00fcnchner Startup-Szene.\",\"sameAs\":[\"http:\/\/cms.munich-startup.net\",\"https:\/\/www.facebook.com\/profile.php?id=100009572160192\",\"https:\/\/x.com\/FlorianDeglmann\"],\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/deglmann\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2017\/10\/Biotech-Presse-Lounge-Oktober-2017-002.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biotech Press Lounge: IZB startups working on medical progress - Munich Startup","description":"On October 12, 2017, the Innovation and Startup Center for Biotechnology (IZB) hosted the sixth Biotech Press Lounge in the Faculty Club G2B.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/29232\/biotech-press-lounge-startups-izb-medical-progress\/","og_locale":"en_US","og_type":"article","og_title":"Biotech Presselounge: IZB-Startups arbeiten am medizinischen Fortschritt - Munich Startup","og_description":"Am 12. Oktober 2017 veranstaltete das Innovations- und Gr\u00fcnderzentrum f\u00fcr Biotechnologie (IZB) die sechste Biotech Presse-Lounge im Faculty Club G2B.","og_url":"https:\/\/cms.munich-startup.net\/en\/29232\/biotech-press-lounge-startups-izb-medical-progress\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_author":"https:\/\/www.facebook.com\/profile.php?id=100009572160192","article_published_time":"2017-10-18T13:29:12+00:00","author":"Florian Deglmann","twitter_card":"summary_large_image","twitter_creator":"@FlorianDeglmann","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Florian Deglmann","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/29232\/biotech-presselounge-startups-izb-medizinischer-fortschritt\/","url":"https:\/\/cms.munich-startup.net\/29232\/biotech-presselounge-startups-izb-medizinischer-fortschritt\/","name":"Biotech Press Lounge: IZB startups working on medical progress - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/29232\/biotech-presselounge-startups-izb-medizinischer-fortschritt\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/29232\/biotech-presselounge-startups-izb-medizinischer-fortschritt\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2017\/10\/Biotech-Presse-Lounge-Oktober-2017-002.jpg","datePublished":"2017-10-18T13:29:12+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/2371b77bb47cd783e9e1f88e88d9f251"},"description":"On October 12, 2017, the Innovation and Startup Center for Biotechnology (IZB) hosted the sixth Biotech Press Lounge in the Faculty Club G2B.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/29232\/biotech-presselounge-startups-izb-medizinischer-fortschritt\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/29232\/biotech-presselounge-startups-izb-medizinischer-fortschritt\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/29232\/biotech-presselounge-startups-izb-medizinischer-fortschritt\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2017\/10\/Biotech-Presse-Lounge-Oktober-2017-002.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2017\/10\/Biotech-Presse-Lounge-Oktober-2017-002.jpg","width":1200,"height":800,"caption":"Redner der Biotech Presselounge am 12. Oktober 2017 im IZB (v.l.n.r.): Dr. Markus Dangl, Senior Vice President Research and Pre-Clinical Development, Medigene AG Evelyn Warner, Chefredakteurin, Labiotech.eu Dr. Jens Altrichter, COO Leukocare AG Dr. Peter Hanns Zobel, Gesch\u00e4ftsf\u00fchrer IZB PhD. Paola Casarosa, Corporate Vice President Therapeutics, B\u00f6hringer Ingelheim"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/29232\/biotech-presselounge-startups-izb-medizinischer-fortschritt\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Biotech Presselounge: IZB-Startups arbeiten am medizinischen Fortschritt"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/2371b77bb47cd783e9e1f88e88d9f251","name":"Florian Deglmann","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1e3087740aeaedbec23f0c7300f1beeb?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1e3087740aeaedbec23f0c7300f1beeb?s=96&d=blank&r=g","caption":"Florian Deglmann"},"description":"The exiled Nuremberg resident researched the Munich startup scene as an editor until April 2019.","sameAs":["http:\/\/cms.munich-startup.net","https:\/\/www.facebook.com\/profile.php?id=100009572160192","https:\/\/x.com\/FlorianDeglmann"],"url":"https:\/\/cms.munich-startup.net\/en\/author\/deglmann\/"}]},"og_image":[{"width":1200,"height":800,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2017\/10\/Biotech-Presse-Lounge-Oktober-2017-002.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1508327481:26","_edit_last":"26","_yoast_wpseo_focuskw":"Biotech Presselounge","_yoast_wpseo_metadesc":"Am 12. Oktober 2017 veranstaltete das Innovations- und Gr\u00fcnderzentrum f\u00fcr Biotechnologie (IZB) die sechste Biotech Presse-Lounge im Faculty Club G2B.","_yoast_wpseo_linkdex":"79","_thumbnail_id":"29234","wbounce_status":"default","_yoast_wpseo_primary_category":"5635","_yoast_wpseo_focuskw_text_input":"Biotech Presselounge","_yoast_wpseo_content_score":"30","ms_image_format":"","_ms_image_format":"","ms_dachzeile":"","_ms_dachzeile":"","ms_bump_post_date":"","_ms_bump_post_date":"","guest_author_name":"","_guest_author_name":"","guest_author_image":"","_guest_author_image":"","guest_author_description":"","_guest_author_description":"","ms_post_image_caption":"","_ms_post_image_caption":"","ms_post_image_credit":"","_ms_post_image_credit":"","suppress_startupbox":"","_suppress_startupbox":"","_yoast_wpseo_estimated-reading-time-minutes":"","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/29232"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=29232"}],"version-history":[{"count":0,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/29232\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/29234"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=29232"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=29232"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=29232"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}